Opening Asia for Russia

Sino-Uzbek vaccine effective against new strains of COVID-19

20.04.2021 44 просмотров

The Ministry of Health of Uzbekistan has confirmed the effectiveness of the Chinese-Uzbek vaccine against COVID-19.


The ZF-UZ-VAC2001 vaccine developed in China and undergoing clinical trials in Uzbekistan has shown its effectiveness against three strains of the new coronavirus - South African, British and Brazilian. This was announced on Monday by the press service of the Ministry of Innovative Development of Uzbekistan.

"The effectiveness of the vaccine [ZF-UZ-VAC2001] against new strains of COVID-19 - the British and Brazilian variants, was confirmed," the report says. It is noted that the drug also produces antibodies against the South African strain. “Furthermore, according to the results of laboratory testing of samples conducted in February 2021, the vaccine retained neutralizing activity against the South African variant of the coronavirus,” the ministry said. Biopharmaceutical (Anhui Zhifei Longcom Biopharmaceutical) was launched in Uzbekistan in December 2020. According to the Ministry of Innovations, “90% of the 150 volunteers in the control group, after the second dose, showed an antibody level in the blood above 4.55 Au / ml, which means a sufficient level to neutralize the coronavirus.” A company from China recognized Uzbekistan as a co-author of the drug for the contribution of the republic to its clinical trials.

Новости партнёров